SABRINA GALINDO: Open Payments
NPI 1013690858 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 20 payments from 8 companies in 2025. Trend: 2023 $59 · 2024 $214 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Lilly USA, LLC | 4 | $71 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Actelion Pharmaceuticals US, Inc. | 3 | $66 |
| SCPHARMACEUTICALS INC. | 2 | $45 |
| Edwards Lifesciences Corporation | 2 | $39 |
| Medtronic, Inc. | 1 | $27 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
Products named: MOUNJARO, Adempas, FUROSCIX, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, OPSUMIT, CAPVAXIVE, OPSYNVI, VENASEAL.
Industry payments across CA — which companies pay providers there.
